Skip to main content

Table 8 Metabolism and excretion

From: (Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide as carbonic anhydrase inhibitor: exploration of its in vitro and in silico studies

CYP1A2-inh

CYP2C19-inh

CYP2C9-inh

CYP2D6-inh

CYP3A4-inh

T1/2

CL

0.222

0.835

0.85

0.086

0.605

0.02

3.049